Vascular Biogenics Correlations

VBLTDelisted Stock  USD 0.16  0.01  5.88%   
The correlation of Vascular Biogenics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vascular Biogenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vascular Biogenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Average diversification

The correlation between Vascular Biogenics and NYA is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and NYA in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The ability to find closely correlated positions to Vascular Biogenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vascular Biogenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vascular Biogenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vascular Biogenics to buy it.

Moving against Vascular Stock

  0.78BAC Bank Of America Aggressive PushPairCorr
  0.74HD Home Depot Financial Report 21st of May 2024 PairCorr
  0.68CAT Caterpillar Fiscal Quarter End 31st of March 2024 PairCorr
  0.64PBCRY Bank Central AsiaPairCorr
  0.63BKRKY Bank RakyatPairCorr
  0.62MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.62AXP American Express Fiscal Quarter End 31st of March 2024 PairCorr
  0.61MARA Marathon Digital Holdings Earnings Call This WeekPairCorr
  0.61KO Coca-Cola Aggressive PushPairCorr
  0.58GE General Electric Fiscal Quarter End 31st of March 2024 PairCorr
  0.57BKRKF PT Bank RakyatPairCorr
  0.56JNJ Johnson Johnson Aggressive PushPairCorr
  0.49PPERF Bank Mandiri PerseroPairCorr
  0.49PPERY Bank Mandiri PerseroPairCorr
  0.49AA Alcoa Corp Buyout TrendPairCorr
  0.45PBCRF PT Bank CentralPairCorr
  0.41CSCO Cisco Systems Fiscal Quarter End 30th of April 2024 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
High negative correlations   

Risk-Adjusted Indicators

There is a big difference between Vascular Stock performing well and Vascular Biogenics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vascular Biogenics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Delisting Warning - VBLT

Vascular Biogenics was delisted

The entity Vascular Biogenics with a symbol VBLT was delisted from NASDAQ Exchange. Please try Notable Labs with a symbol NTBL from now on. Check all delisted instruments accross multiple markets.

Vascular Biogenics Corporate Directors

Vascular Biogenics corporate directors refer to members of a Vascular Biogenics board of directors. The board of directors generally takes responsibility for the Vascular Biogenics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Vascular Biogenics' board members must vote for the resolution. The Vascular Biogenics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Philip SerlinNon-Executive Independent DirectorProfile
Dan GelvanNon-Executive Independent DirectorProfile
Ron CohenNon-Executive Independent DirectorProfile
Ruth AlonNon-Executive Independent DirectorProfile

Still Interested in Vascular Biogenics?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Vascular Stock

If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios